Healthcare Research | Market Insights & Strategic Analysis

  Metastatic Castration-Resistant Prostate Cancer  Market According to the IMARC Group, The 7 major metastatic castration-resistant prostate cancer markets reached a value of USD 7,275.4 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 12,840.0 Million by 2035, exhibiting a growth rate (CAGR) of 5.3% during 2025-2035. This can be attributed to the emerging popularity of targeted therapies, such as enzalutamide, abiraterone acetate, apalutamide, etc., that can block specific pathways involved in the proliferation and progression of tumor growth. Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of prostate cancer that progresses despite hormone therapy aimed at lowering androgen levels. The metastatic castration-resistant prostate cancer market is driven by various factors, including the rising prevalence of prostate cancer, particularly among the aging male population, which is the primary demographic for this disea...

  Cutaneous Lupus Erythematosus  Market According to the IMARC Group, the 7 major cutaneous lupus erythematosus markets reached a value of USD 237.8 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 385.5 Million by 2035, exhibiting a growth rate (CAGR) of 4.48% during 2025-2035.  This can be attributed to the growing need for biological treatments, which target immune system components to treat severe or resistant cutaneous lupus erythematosus (CLE) instances. Cutaneous lupus erythematosus (CLE) is a type of lupus that predominantly affects the skin, causing several dermatological manifestations without affecting internal organs. The cutaneous lupus erythematosus market is witnessing significant growth due to various key factors. Primarily, the market is driven by the rising prevalence of autoimmune diseases and increasing awareness about early diagnosis and management of lupus-related conditions. Advancements in dermatological and immu...

  Coronary Heart Disease Market According to the IMARC Group, the The 7 major coronary heart disease markets are expected to exhibit a CAGR of 5.17% during 2024-2034 This can be attributed to the emerging popularity of enhanced external counterpulsation (EECP) therapy, owing to its numerous advantages, such as increased exercise tolerance and reduced need for medication. Coronary heart disease represents a medical condition that arises when the arteries carrying blood to the cardiac muscle become narrowed or blocked. The rising prevalence of lifestyle-related risk factors, including smoking, unhealthy diets, physical inactivity, and stress is augmenting the coronary heart disease market growth. Besides this, the aging population is fueling the demand for diagnostic and therapeutic solutions, as older individuals are at a higher risk of developing cardiovascular conditions. Advancements in medical technology are significantly enhancing the market landscape, with innovations in diagn...

  Congenital Adrenal Hyperplasia  Market The 7 major congenital adrenal hyperplasia markets reached a value of US$ 23.7 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach US$ 44.9 Million by 2035, exhibiting a growth rate (CAGR) of 5.98% during 2025-2035. Congenital adrenal hyperplasia (CAH) represents a group of genetic diseases that affect the adrenal glands, which are small glands that produce steroid hormones. The congenital adrenal hyperplasia market is experiencing significant growth driven by the increasing awareness and early diagnosis of genetic disorders due to advancements in newborn screening programs. Besides this, the growing prevalence of CAH and advances in molecular genetics are spurring the demand for targeted and effective therapies, thereby catalyzing the congenital adrenal hyperplasia market expansion. Pharmaceutical companies are focusing on developing innovative treatments, such as modified glucocorticoids with reduced side effects an...

  The athlete's foot market reached a value of USD 690.4 Million across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 910.2 Million by 2035, exhibiting a growth rate (CAGR) of 2.57% during 2025-2035. The athlete's foot market in 2025 is growing consistently, fueled by growing awareness, heightened incidences, and ongoing innovation in treatment options. Athlete's foot, or tinea pedis, is a frequent fungal infection of the feet' skin, commonly extending to toenails and hands. Although not life-threatening, it is painful, itchy, and inconvenient and thus generates great demand for quick-acting and effective treatments. One primary explanation for the increasing prevalence of athlete's foot is increased sports and fitness activity participation. As more individuals share showers, swimming pools, and gymnasium facilities, there is an increased risk of fungal infection transmission. Rising wo...

  The ankylosing spondylitis market reached a value of USD 5.1 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 10.2 Billion by 2035, exhibiting a growth rate (CAGR) of 6.53% during 2025-2035. The year 2025, for instance, is seeing tremendous growth in the androgenetic alopecia hair market. Worldwide, male or female pattern baldness disorders affect a large populace, and the figures are only growing worldwide with genetics, lifestyle habits, and increasing stress levels being some causes. Treatment is sought by increasing numbers of patients, thus augmenting the demand for advanced hair restoration solutions, consequently impacting an ever-booming market. It has created a new style for diagnostic and treatment regimes for this disorder. Artificial intelligence tools and imaging techniques offer individual assessments for hair loss. The patient can also get treated by consulting a remote phys...

  The androgenetic alopecia market reached a value of USD 1,805.5 Million across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 2,786.5 Million by 2035, exhibiting a growth rate (CAGR) of 4.03% during 2025-2035. Androgenetic alopecia, best known as pattern hair loss, is among the most common types of thinning hair seen in both men and women. As more people notice the condition and new treatments emerge, the worldwide market for related products and services is set to grow sharply by 2025. Every year millions of people watch their hair grow sparser or recede. Doctors say genes and hormones are the main culprits, especially the body;s sensitivity to dihydrotestosterone, or DHT. Yet rising pollution, unbalanced diets, and everyday stress seem to be pushing more people toward early hair loss. The market keeps expanding thanks to older adults living longer and more people worrying about how they look. With so...